Medibios Laboratories IPO – Review, Allotment Status, Subscription, Price, Date & more

Last Updated Date: Nov 18, 2022

The Medibios Laboratories Limited is launching its IPO soon. Medibios Laboratories Limited a pharma company based in Mumbai is all set to float an IPO. Let’s have a detailed review of Medibios Laboratories IPO and an in-depth analysis of the IPO release date, IPO offer price, Medibios Laboratories IPO subscription, IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things.

Open Demat Account - Offers

Medibios Laboratories IPO Review & Ratings

Medibios Laboratories IPO Ratings & Review
Criteria	Ratings
Industry Sentiments	6.1/10
Industry Ranking	6.3/10
Company Background	6.5/10
Company Reputation	6.2/10
Competitive Edge	6.3/10
Financial Statements	6.4/10
Popularity Index	6.5/10
Promoters Reputation	6.5/10
Retail Appetite	6.7/10
Top Brokers Review	6.0/10
Overall Ratings	6.4/10
Star Ratings	★★★☆☆

Summary of Medibios Laboratories IPO

Medibios Laboratories IPO The Medibios lab which is powered by great minds is a firm that has widespread recognition. There are clients all over the world. Since the pharma industry is doing too good, if you buy the IPO from this firm, it is sure to do well.

Africa, South East Asia, Latin and CIS nations have accredited the quality of the products from Medibios Laboratories Limited. The products are manufactured by a specialized and dedicated Research and Development team. The company’s location is in India’s global market place, Mumbai. This makes it easy to get recognition for its products. This is yet another reason why one should invest in this IPO. Up to 22, 90,800 Equity Shares of Rs. 10/- each for cash at a price of Rs. [·]/- per share aggregating to Rs. [·] Lakhs.

The promoters of this company are

Tushar Korday
Rajendra Gole
Shailaja Korday
Jyoti Gole

The lead manager to the issue is Asit C. Mehta Investment Interrmediates Ltd and the registrar to the issue is Bigshare Services Private Limited.

Subscribe to Medibios Laboratories IPO

Medibios Laboratories IPO Date

The opening and the closing date of the Medibios Laboratories IPO is not known yet.

Medibios Laboratories IPO Subscription

	Subscription
Day 1	X
Day 2	X
Day 3	X
Day 4	X
Day 5	X

The IPO issue date has not been announced yet. Once the IPO date has been issued, the subscription details will be updated regularly.

Medibios Laboratories IPO Allotment Status

Since the issue date has not been fixed yet, the Allotment Status is not out. The Allotment status will be announced about 3-4 weeks of the IPO issue date.

Medibios Laboratories IPO Price Band

The face value of the Equity Shares of our Company is Rs 10/- each and the Issue Price is Rs X the share price.

Medibios Laboratories IPO Issue Size

The exact price of the issue size is not known, though the number of equity shares to be issued is known.

Medibios Laboratories IPO Equity Share Offerings

Up to 22,90,800 Equity Shares of Rs. 10/- each for cash at a price of Rs. [·]/- per share aggregating to Rs. [·] Lakhs.

List of Upcoming IPOs in 2018

Medibios Laboratories Limited – Company Overview

Located in the bustling city of Mumbai, this pharma company has got regular clients both inside and outside India. The main aim of the company is to manufacture internationally acceptable products.

These are some of the range of products that are manufactured by the company and they are in standard with the WHO. The company has customers all over the world.

Neutraceuticals
Central Nervous System
Respiratory System
Genito – urinary System
Cardivasculars
Antiretrovirals
Antifungals
Antibacterials

Apart from the R&D team, the products that are manufactured are put through a serious quality assurance check before they are packed. The health of the people is the main concern of this firm.

The key management personnel of the company

Sangeeta Dhanuka, Company Secretary & Compliance Officer and the MD of the firm.

Medibios Laboratories – Financial Statements

A quick look into the past financial performance of the company to understand its performance of business and evaluate the growth prospectus:

Assets of the Company

Assets (in INR & Lakhs)

	31-Mar-17	31-Mar-16	31-Mar-15	31-Mar-14	31-Mar-13
Non-Current Asset	1977.93	1830.31	1726.31	1590.3	1571.78
Current Assets	2116.67	1456.22	1805.13	1417.8	1331.2
Total Assets	4248.14	3441.91	3693.4	3089.29	2986.35

Revenue & PAT of the Company

Revenue and Profit (in lakhs)

	31-Mar-17	31-Mar-16	31-Mar-15	31-Mar-14	31-Mar-13
Revenue	4960,04	4008.59	3723.17	3621.75	3307.96
Profit After Tax	564.89	320.55	243.02	133.95	94.35

Earnings per Equity Share (in Lakh)

	31-Mar-17	31-Mar-16	31-Mar-15	31-Mar-14	31-Mar-13
Basic	7.95	4.51	3.42	1.89	1.33
Diluted	7.95	4.51	3.42	1.89	1.33

From the above statements, one could find that the garment company has performed well in the past few years.

Medibios Laboratories IPO – Promoters

The promoters of this company are

Tushar Korday
Rajendra Gole
Shailaja Korday
Jyoti Gole

Interest of Promoters in the Promotion of the company

The promoters of the company have promoted the company and they are eligible to obtain the dividends from the company. The promoters of the company also hold some of the key positions in decision making.

Interest of Promoter in the Property of the company

The promoters of the company have not shown any interest in acquiring the property of the company. No property has been acquired by them two years since the red draft herring prospectus was filed.

Interest of Promoter in the Intellectual Rights of the company

The promoters of the company do not have any interest in any other properties of the company.

Medibios Laboratories IPO Offer Details or Issue Details

Particulars	No. Of Equity Shares
Equity Shares Offered	Up to 22,90,800 Equity Shares of Rs. 10/- each for cash at a price of Rs. [·]/- per share aggregating to Rs. [·] Lakhs.
Of which:
Reserved for Market Makers	Up to 1,15,200 Equity Shares of Rs. 10/- each for cash at a price of Rs. [·]/- per share aggregating Rs. [·] Lakhs.
Net Issue to the Public	–
Of which:
Retail Investors Portion	The number of Equity Shares in multiples of [●] Equity Shares at an Issue price of Rs. [●] each, such that the Application Value does not exceed Rs. 2.00 Lakh
Non-Retail Investors Portion	A number of Equity Shares in multiples of [●] Equity Shares at an Issue price of Rs. [●] each, such that the Application Value exceeds Rs. 2.00 Lakh.
Equity Shares outstanding prior to the Issue	71,04,600 Equity Shares of the face value of Rs. 10/- each
Equity Shares outstanding after the Issue	Up to 86,59,800 Equity Shares of the face value of Rs. 10/- each

Medibios Laboratories IPO Issue Object

These are the IPO Issue Objects of the company

To modernize and expand the existing the general division of the company and to set up a veterinary division
To market the products and register the formulations
The IPO money would also be used for general corporate purposes

List of Upcoming IPOs in 2018

G R InfraProjects IPO	Bright Solar IPO	Shree Vasu Logistics IPO	Finecure Pharmaceuticals IPO
Yash Highvoltage IPO	Latteys Industries IPO	Sonam Clock IPO	Shiva Industrial IPO

Medibios Laboratories IPO – Basis of the Offer Price

The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors. The face value of the Equity Shares of our Company is ` 10/- each and the Issue Price is Rs [●] the share price.

Qualitative factors are:

Technical know-how
Geographical location
Recurring business from existing customers
Competitive cost
Strong regulatory team
Focus on quality control
Experienced management team
Diversified product

The relevant quantitative factors are:

Basic & Diluted Earnings per share (EPS) (Face value of ₹ 10 each), as adjusted for change in capital
Price Earning (P/E) Ratio in relation to Price of ₹ [●] per Equity Share
Average Return on Net worth (RoNW)
Minimum Return on Net Worth after Issue to maintain Pre-Issue EPS
Net Asset Value (NAV) per Equity Share (Face Value Rs 10 each)
Comparison of Accounting Ratios with Industry Peers

List of Latest IPOs of 2018

SoftTech Engineers IPO	Akshar Spintex IPO	Godha Cabcon Insulation IPO	Indo US Biotech IPO
E2E Networks IPO	Dr. Lalchandani Labs IPO	Kims Hospitals IPO	Megastar Foods IPO

Medibios Laboratories IPO Lead Managers

Lead Managers

Asit C. Mehta Investment Intermediates Ltd

Medibios Laboratories IPO Registrar to offer

Registrar to the Issue

Bigshare Services Private Limited

Medibios Laboratories IPO Review by Top 10 Stock Brokers

Top Stock Brokers Review	Company Reputation	Competitive Edge	Financial Statement	Popularity Index	Promters Reputation
Angel Broking	6.4/10	6.6/10	6.0/10	6.4/10	6.0/10
Sharekhan	6.2/10	6.1/10	6.6/10	6.1/10	6.2/10
Kotak Securities	6.3/10	6.2/10	6.3/10	6.4/10	6.3/10
ICICI Direct	6.3/10	6.3/10	6.7/10	6.1/10	6.1/10
IIFL	6.2/10	6.2/10	6.8/10	6.0/10	6.1/10
Edelweiss	6.2/10	6.3/10	6.3/10	6.3/10	6.2/10
Zerodha	6.3/10	6.4/10	6.3/10	6.3/10	6.0/10
5Paisa	6.1/10	6.4/10	6.3/10	6.1/10	6.1/10
Karvy	6.3/10	6.3/10	6.2/10	6.1/10	6.0/10
Motilal Oswal	6.3/10	6.4/10	6.3/10	6.5/10	6.4/10